You are here

Bio-Hep B®

A recombinant hepatitis B vaccine that integrates the S, pre-S1, and pre-S2 surface proteins of the hepatitis B virus. Enables successful immunization with significantly lower doses of vaccine than other recombinant hepatitis B vaccines. Licensed to Bio-Technology General, Inc., a subsidiary of Ferring Inc. Bio-Hep-B is marketed in Israel and registrations in other countries are under way.